Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011
Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009
Characterisation of patients with difficult-to-treat and treatment-resistant severe asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
Peculiarities of clinical-functional manifestations in severe bronchial asthma patients depending on the characteristics if local immunity Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Macrolides targeting multiple immune pathways in asthma and COPD Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021
The immunological features of the severe steroid-resistant asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021
Immune status in patients with bronchial asthma exacerbation and comorbide digestive system diseases Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011
Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza Source: Eur Respir J, 54 (4) 1900949; 10.1183/13993003.00949-2019 Year: 2019
Different features between subjects with asthma diagnosis and with only asthmatic symptoms Source: Annual Congress 2010 - Methods in respiratory epidemiology Year: 2010
The pharmacogenetic aspects of corticosteroid metabolism in patients with severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 523s Year: 2006
Characterisation of severe, steroid-dependent asthma patients who initiate biologics versus those who do not Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002
How cultured epithelial cells from asthma and COPD patients deal with pathogens: defective anti-rhinovirus responses in asthma Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008
Virus-induced exacerbation in patients with different forms of non-allergic late-onset asthma Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003